Literature DB >> 16650735

Comorbid diagnoses in patients meeting criteria for the schizophrenia prodrome.

Joanna L Rosen1, Tandy J Miller, Jennifer T D'Andrea, Thomas H McGlashan, Scott W Woods.   

Abstract

While schizophrenia is often associated with a variety of concurrent psychiatric symptoms, little attention has been paid to the prevalence of psychiatric comorbidity in prodromal patients. The current study examines the presence of comorbid current and lifetime psychiatric conditions in prospectively identified prodromal patients. The results suggest that like their schizophrenic counterparts, prodromal patients experience a wide array of comorbid psychiatric syndromes, with the most common being Major Depressive Disorder and Cannabis Dependence. Results also suggest that Cannabis Dependence may be more common among prodromal versus help-seeking control patients. These findings lay the groundwork for further examination of the role that comorbid conditions play in the development, course, and severity of schizophrenia.

Entities:  

Mesh:

Year:  2006        PMID: 16650735     DOI: 10.1016/j.schres.2006.03.034

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  56 in total

1.  Identification and characterization of prodromal risk syndromes in young adolescents in the community: a population-based clinical interview study.

Authors:  Ian Kelleher; Aileen Murtagh; Charlene Molloy; Sarah Roddy; Mary C Clarke; Michelle Harley; Mary Cannon
Journal:  Schizophr Bull       Date:  2011-11-17       Impact factor: 9.306

2.  Specificity of Incident Diagnostic Outcomes in Patients at Clinical High Risk for Psychosis.

Authors:  Jadon R Webb; Jean Addington; Diana O Perkins; Carrie E Bearden; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Robert K Heinssen; Larry J Seidman; Sarah I Tarbox; Ming T Tsuang; Elaine F Walker; Thomas H McGlashan; Scott W Woods
Journal:  Schizophr Bull       Date:  2015-09       Impact factor: 9.306

3.  Effects of Δ-THC on Working Memory: Implications for Schizophrenia?

Authors:  Nehal P Vadhan; Mark R Serper; Margaret Haney
Journal:  Prim psychiatry       Date:  2009-01-01

4.  Age-related trajectories of social cognition in youth at clinical high risk for psychosis: An exploratory study.

Authors:  Charlie A Davidson; Danijela Piskulic; Jean Addington; Kristen S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Carrie E Bearden; Daniel H Mathalon; Scott W Woods; Jason K Johannesen
Journal:  Schizophr Res       Date:  2018-05-08       Impact factor: 4.939

5.  Chronic cannabinoid exposure reduces phencyclidine-induced schizophrenia-like positive symptoms in adult rats.

Authors:  Maria Sabrina Spano; Liana Fattore; Francesca Cadeddu; Walter Fratta; Paola Fadda
Journal:  Psychopharmacology (Berl)       Date:  2012-08-19       Impact factor: 4.530

6.  Sleep dysfunction and thalamic abnormalities in adolescents at ultra high-risk for psychosis.

Authors:  Jessica R Lunsford-Avery; Joseph M Orr; Tina Gupta; Andrea Pelletier-Baldelli; Derek J Dean; Ashley K Smith Watts; Jessica Bernard; Zachary B Millman; Vijay A Mittal
Journal:  Schizophr Res       Date:  2013-10-04       Impact factor: 4.939

7.  Symptom dimensions and functional impairment in early psychosis: more to the story than just negative symptoms.

Authors:  Daniel Fulford; Tara A Niendam; Erin G Floyd; Cameron S Carter; Daniel H Mathalon; Sophia Vinogradov; Barbara K Stuart; Rachel L Loewy
Journal:  Schizophr Res       Date:  2013-04-12       Impact factor: 4.939

8.  The 'at-risk mental state' for psychosis in adolescents: clinical presentation, transition and remission.

Authors:  Patrick Welsh; Paul A Tiffin
Journal:  Child Psychiatry Hum Dev       Date:  2014-02

9.  Cannabis and Psychosis: What Can Daily Diaries Tell Us About Who is Vulnerable?

Authors:  David Kimhy; Kelly Durbin; Cheryl M Corcoran
Journal:  Prim psychiatry       Date:  2009

10.  Neurocognition and conversion to psychosis in adolescents at high-risk.

Authors:  D J Walder; V Mittal; H D Trotman; A L McMillan; E F Walker
Journal:  Schizophr Res       Date:  2008-02-20       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.